UB
CPRX

UMB Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

UMB Bank’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5K Buy
1,003
+322
+47% +$9.5K ﹤0.01% 1501
2026
Q1 		$16.9K Buy
681
+91
+15% +$2.17K ﹤0.01% 1665
2025
Q4 		$13.8K Buy
590
+160
+37% +$3.56K ﹤0.01% 1692
2025
Q3 		$8.47K Buy
430
+3
+0.7% +$62 ﹤0.01% 1742
2025
Q2 		$9.27K Buy
427
+10
+2% +$236 ﹤0.01% 1629
2025
Q1 		$10.1K Buy
417
+135
+48% +$3.04K ﹤0.01% 1545
2024
Q4 		$5.88K Hold
282
– – ﹤0.01% 1652
2024
Q3 		$5.61K Buy
282
+140
+99% +$2.6K ﹤0.01% 1690
2024
Q2 		$2.2K Buy
142
+92
+184% +$1.43K ﹤0.01% 1740
2024
Q1 		$797 Buy
+50
New +$753 ﹤0.01% 1850

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UMB Bank's CPRX Position: Q2 2026 in Review

UMB Bank increased its Catalyst Pharmaceutical (CPRX) stake by 47% in Q2 2026, buying an estimated $9.5K and bringing the position to 1,003 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

UMB Bank first reported a position in CPRX in Q1 2024 and has held it in 10 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • UMB Bank held 1,003 shares of Catalyst Pharmaceutical worth $31.5K as of Q2 2026.
  • UMB Bank bought 322 Catalyst Pharmaceutical shares in Q2 2026, an estimated $9.5K.
  • Catalyst Pharmaceutical made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1501 holding.
  • UMB Bank first reported a position in Catalyst Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.